Health
Results: 8701-8712 of 9411

Implantica's RefluxStop™ health economic research, showing superior cost-effectiveness, has received top-recognition at ISPOR, the world's leading European Health-Economics Conference

SciBase and Skin and Cancer Institute partner to advance AI-driven skin cancer detection in California

Exciting Progress | Gritgen Therapeutics Completed Patients Enrollment in China’s First Gene Therapy Investigator-Initiated Trial for Hemophilia A and also Achieved the First Patient Dosed in China Phase I Trial in Patients with Severe Hemophilia A

Vertex and CRISPR Therapeutics Announce Authorization of the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), by the United Kingdom MHRA for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia





